Cambridge has a long-standing interest in using human samples for primary research and this is underpinned by a DIAMOND Prostate Cancer Biorepository which holds over 2,000 samples from patients are various stages of the disease.  This has allowed us to explore a number of projects around early detection, translational application of laboratory findings and lead multi-centre bio-markers studies.

We welcome collaborations and access the repository through application through the Cambridge Urology Translation Research and Clinical Trials Office, and interested parties can contact the DIAMOND chief investigator Vincent Gnanapragasm via the Contact Form.